U.S. Infrastructure Stock News

In the last week, the market has stayed flat, but it's up 20% over the past year, with earnings forecast to grow by 17% annually. In such a landscape, identifying stocks that balance potential growth with financial stability is crucial. Penny stocks may be an older term, yet they remain relevant for investors seeking opportunities in smaller or newer companies; those backed by strong fundamentals can offer both value and growth potential.

Mosaic (MOS) has just closed a new US$2.0b senior notes offering and outlined plans to use most of the proceeds to buy back shorter term bonds, refinance debt and fund general corporate purposes. See our latest analysis for Mosaic. Mosaic shares have reacted positively to the refinancing news with a 1-day share price return of 5.16%, although year to date the share price return is down 11.15% and the 1-year total shareholder return has declined 29.09%, pointing to fading longer term...

Alkermes (ALKS) drew investor attention after amending its February 2026 credit agreement, reducing interest rate spreads on its senior secured term loan A and term loan B facilities maturing in 2031. See our latest analysis for Alkermes. Alkermes shares trade at US$50.18 after a 1-day share price return of 1.41%, and the stock shows strong momentum with a 90-day share price return of 35.81% and a 1-year total shareholder return of 73.21%, alongside an 82.72% total shareholder return over...

Regeneron Pharmaceuticals (NasdaqGS: REGN) received FDA approval for Pasatru (garetosmab-grts) as the first treatment for adults with fibrodysplasia ossificans progressiva to reduce new heterotopic ossification lesions and flare-ups. The approval is based on Phase 3 trial results and introduces a new therapeutic franchise for Regeneron beyond its existing portfolio. Pasatru targets a rare and severely disabling condition, expanding Regeneron's reach in rare disease treatments. This kind of...

In recent weeks, AbbVie has highlighted the pending review of a subcutaneous induction option for SKYRIZI in Crohn’s disease, continued portfolio expansion through deals such as its roughly US$10.90 billion Apogee Therapeutics acquisition, and the ongoing recognition of its long-running immunology scholarship program. Together, these developments underscore how heavily AbbVie’s outlook is tied to SKYRIZI’s future use, while it simultaneously invests in new therapies and reinforces its image...

Glaukos stock has delivered very strong gains over the last five years, yet the current valuation checks and market multiples suggest the shares now lean expensive rather than clearly cheap. Glaukos has returned 260.2% over the past 5 years, which puts extra focus on whether the current price still leaves enough room for a reasonable long term return. Expectations for continued growth in ophthalmology treatments can support today’s price, while any setback in execution or slower revenue...

Upcoming Q2 2026 earnings call puts Ollie's Bargain Outlet Holdings (OLLI) in focus Ollie's Bargain Outlet Holdings (OLLI) is drawing attention ahead of its upcoming second quarter fiscal 2026 earnings release on Wednesday, September 2, 2026, before the market opens. Management will host a conference call at 8:30 a.m. Eastern Time to discuss the results and answer investor questions, with a live webcast and replay available through the company’s Investor Relations website. See our latest...

T. Rowe Price Group previously announced that its Board of Directors declared a quarterly dividend of US$1.30 per share, payable on September 29, 2026, to stockholders of record as of September 15, 2026. Despite this cash return to shareholders, analysts remain cautious as mixed Q2 2026 results, weak long-term growth, and continued net client outflows weigh on their views. With analysts still concerned about ongoing net client outflows, we'll now examine how this latest news shapes T. Rowe...

Cirrus Logic (CRUS) heads into its August 11 appearance at the KeyBanc Technology Leadership Forum with fresh attention on its custom smartphone revenue, along with renewed debate about whether its current share price reflects underlying cash flows. See our latest analysis for Cirrus Logic. Recent trading reflects mixed sentiment. Cirrus Logic’s share price is up 1.02% over the last day but down 13.69% over 30 days and 29.14% over 90 days. Its 3-year total shareholder return of 47.72% points...

Neogen Corporation (NasdaqGS: NEOG) announced the resignation of board member Thierry Bernard from its board of directors. The company disclosed the board change as a governance update for shareholders and other stakeholders. Bernard's departure adjusts the composition of Neogen's board, which is responsible for oversight of management and long term direction. Board changes at Neogen sit within a wider pattern of investors watching for resilient leadership and steadier business models,...

TD SYNNEX stock has delivered very strong gains over the past few years, while both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples currently point to the shares trading below what these models suggest. Over the past 3 years, TD SYNNEX has returned 164.3%, which puts added focus on whether the current share price still leaves a valuation cushion. Expectations for continued cash flow generation can support the current valuation. However, any pressure on...

Delek Logistics Partners, LP recently completed a US$200 million follow-on equity offering of 4,000,000 common units at US$50 per unit, with Huntington Securities, Inc. and Citizens JMP Securities, LLC added as co-lead underwriters. This capital raise meaningfully increases the partnership’s equity base, which could influence future funding decisions, distribution policy, and balance sheet flexibility. Next, we’ll examine how this US$200 million equity issuance may reshape Delek Logistics...

GrowthLoop launched a new end-to-end commerce media network solution that integrates with The Trade Desk (NasdaqGM:TTD) as a key adtech partner. The platform is designed for retail and commerce media teams to run campaigns with a more unified advertising technology stack. GrowthLoop's use of The Trade Desk aims to support more seamless media activation and workflow management across commerce media networks. This kind of collaboration in commerce media and AI driven adtech is part of a wider...

Recent Underperformance Puts Cooper Companies Under Closer Scrutiny Cooper Companies (COO) has drawn investor attention after its shares fell 9.5% over the past six months while the S&P 500 gained 12.9%, raising questions about sentiment toward the stock. See our latest analysis for Cooper Companies. At a share price of US$76.73, Cooper Companies has seen a 30 day share price return of 7.18% and a 90 day share price return of 22.08%. The 1 year total shareholder return of 4.39% contrasts with...

Popular (BPOP) is back in focus after a period of strong share price gains over the past five years and solid recent momentum. This has prompted investors to reassess what is driving the bank’s current valuation. See our latest analysis for Popular. Over the past year Popular’s share price return has gained momentum, with a year to date share price return of 35.42% and a 1 year total shareholder return of 46.28% supporting a strong multi year performance profile. If you want to see what else...

Liquidia (LQDA) is back in focus after its second quarter 2026 report showed revenue of US$171.68 million and net income of US$74.72 million, reversing the loss reported a year earlier. See our latest analysis for Liquidia. The latest earnings report appears to be a key driver behind Liquidia’s recent move, with the share price at US$75.33 and a year to date share price return of 139.9%. Despite some recent pullback over the past week and month, the 90 day share price return of 21.56%,...

Apple Hospitality REIT (APLE) is in focus after receiving a Zacks Rank of #2 (Buy). This ranking is tied to an improving earnings outlook and valuation metrics that compare favorably with other real estate investment trusts. See our latest analysis for Apple Hospitality REIT. The recent Zacks upgrade comes as Apple Hospitality REIT’s share price has built positive momentum over 2024. The stock has a 35.66% year to date share price return and a 42.92% 1 year total shareholder return. The...

Resideo Technologies recently reported second-quarter 2026 results, with sales of US$1,981 million and net income of US$97 million, and confirmed standalone revenue guidance for the third quarter and full year 2026. The company also appointed experienced finance executive Shane Harrison as Chief Financial Officer, signaling a renewed focus on financial discipline and investor communication following the ADI spin-off. We’ll now examine how Resideo’s stronger earnings and the appointment of a...

Shares of Gaming and Leisure Properties (GLPI) recently pulled back after concerns around the financial health of Bally’s, the company’s second largest tenant, drew investor attention to tenant risk and project financing progress. See our latest analysis for Gaming and Leisure Properties. Over the past year, Gaming and Leisure Properties has seen its share price drift lower, with the 90 day share price return down 9.68% and the 1 year total shareholder return down 3.25%. This points to fading...

BOK Financial stock has delivered a strong 86.1% return over the past three years, yet its valuation checks paint a mixed picture, with an intrinsic value estimate suggesting a discount while traditional earnings multiples lean the other way. BOK Financial has returned 86.1% over three years, which puts extra focus on whether recent gains are already pricing in much of the good news. Expectations for steady profitability and balance sheet strength may support the intrinsic value estimate. At...

United States Antimony earnings put recent stock moves in focus United States Antimony (UAMY) stock is in focus after the company reported second quarter 2026 results, with sales of US$7.93 million and net income of US$0.11 million, alongside a first half net loss. See our latest analysis for United States Antimony. The earnings release, share repurchase announcement, and revised 2026 revenue outlook have arrived alongside sharp short term moves in United States Antimony stock. Recent gains...

OPKO Health stock has rebounded in the short term, yet after a five year stretch of weak returns and a low overall value score, the current market price raises questions about how much upside is already reflected in the valuation. Over the last 5 years, OPKO Health shareholders have seen the stock decline 61.8%, which points to a long period where expectations have not been rewarded. The recent $125 million senior notes backed by mazdutide royalties can support funding for research,...

In recent days, Boot Barn Holdings has attracted investor attention as its ongoing store expansion and associated revenue growth have brought fresh focus to the company’s underlying business performance. Analysts and investors are also debating whether Boot Barn’s current valuation fully reflects its long‑term earnings assumptions, especially given concerns about possible overexpansion and pressure on margins from rising costs or customer resistance to higher prices. Next, we’ll examine...

SK hynix stock has slipped about 7.1% year to date, yet current market multiples still screen it as undervalued and the broader valuation checks point to a mixed picture rather than a clear bargain or an obvious premium. Year to date, SK hynix is down 7.1%. This suggests recent news flow and sentiment have not fully carried through into sustained price gains. The record share buyback and cancellation plan, alongside large commitments to new memory plants, can support long term value...